The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 101–200 of 784
Alcohol, vitamin A, and cancer
Wang, X. (2005) · Alcohol · doi:10.1016/j.alcohol.2005.04.006 · Cited by 92
Synthesis and Biophysical Characterization of Chlorambucil Anticancer Ether Lipid Prodrugs
Pedersen, P. J., Christensen, M. S., Ruysschaert, T., Linderoth, L., Andresen, T. L., Melander, F., Mouritsen, O. G., Madsen, R., & Clausen, M. H. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900091h · Cited by 97
Rational design of RAR‐selective ligands revealed by RARβ crystal stucture
Germain, P., Kammerer, S., Pérez, E., Peluso‐Iltis, C., Tortolani, D., Zusi, F. C., Starrett, J., Lapointe, P., Daris, J., Marinier, A., et al. (2004) · EMBO reports · doi:10.1038/sj.embor.7400235 · Cited by 89
“…activities exerted by the three RARs, which are the basis for the well-established cancer therapeutic and cancer preventive activity of retinoids (Altucci & Gronemeyer, 2001; Sun & Lotan, 2002), assess the role of the suspect tumour suppressor RARb and will aid in generating novel retinoids with…”
BackgroundSelf-citationChang, J., Zhong, R., Tian, J., Li, J., Zhai, K., Ke, J., Lou, J., Chen, W., Zhu, B., Shen, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0045-8 · Cited by 91
Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
Greiner, J., Bullinger, L., Guinn, B., Döhner, H., & Schmitt, M. W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1102 · Cited by 108
Flavonoids Intake and Risk of Lung Cancer: A Meta-analysis
Tang, N., Zhou, B., Wang, B., Yu, R., & Ma, J. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp028 · Cited by 91
“Considerable attention has been paid to vitamins such as vitamin A, C and E from fruits and vegetables because of their roles as regulators of cell differentiation or antioxidants ( 5 ,6).”
BackgroundTargeting the retinoic acid signaling pathway as a modern precision therapy against cancers
Lavudi, K., Nuguri, S. M., Olverson, Z. A., Dhanabalan, A. K., Patnaik, S., & Kokkanti, R. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1254612 · Cited by 99
“A prominently studied disease is acute promyelocytic leukemia (APL), which is caused by the fusion genes PML-RARα and PLZF-RARα, which results in the atypical selection of corepressors suppressing the RA-targeted genes responsible for the terminal differentiation of promyelocytes (Altucci and Gronemeyer, 2001).”
BackgroundRetinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease
de Lema, G. P., Lucio-Cazaña, F. J., Molina, A., Luckow, B., Schmid, H., de Wit, C., Moreno‐Manzano, V., Banas, B., Mampaso, F. M., & Schlöndorff, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00850.x · Cited by 91
“tRA is a natural active derivate of vitamin A that regulates a broad range of biologic processes through specific nuclear receptors lretinoic acid receptors (RAR-α, RAR-β, and RAR-γ or RXR-α, RXR-β, and RXR-γ)r, which are structurally and functionally related to glucocorticoid receptor”
BackgroundRegulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations
le Maire, A., Teyssier, C., Balaguer, P., Bourguet, W., & Germain, P. (2019) · Cells · doi:10.3390/cells8111392 · Cited by 88
Alchanati, I., Nallar, S. C., Sun, P., Gao, L., Hu, J., Stein, A., Yakirevich, E., Konforty, D., Alroy, I., Zhao, X., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209708 · Cited by 92
“Retinoids are a class of vitamin A metabolites and/or synthetic derivatives, which are used for treatment of several cancers and other disorders (Thacher et al., 2000; Altucci and Gronemeyer, 2001).”
BackgroundIntake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata
Wise, L. A., Radin, R. G., Palmer, J. R., Kumanyika, S., Boggs, D. A., & Rosenberg, L. A. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.016600 · Cited by 94
Jensen, S. S., Andresen, T. L., Davidsen, J. R., Høyrup, P., Shnyder, S. D., Bibby, M. C., Gill, J. H., & Jørgensen, K. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1451.3.11 · Cited by 86
Indra, A. K., Castañeda-Saucedo, E., Antal, M. C., Jiang, M., Messaddeq, N., Meng, X., Löhr, C. V., Gariglio, P., Kato, S., Wahli, W., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700672 · Cited by 84
“, 1994), whereas natural and synthetic retinoids are used for treatment of skin disorders including psoriasis and acnea (Livrea, 2000), and as chemopreventive agents for epidermal cancers (Altucci and Gronemeyer, 2001; Sun and Lotan, 2002).”
BackgroundSantos, M. D. L., Zambrano, A., & Aranda, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0623 · Cited by 92
“activity, allowing the use of low retinoid concentrations and reducing its side effects (20).”
BackgroundAbu, J., Batuwangala, M., Herbert, K. E., & Symonds, P. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70319-3 · Cited by 84
Stem cells in breast tumours: Are they ready for the clinic?
Ablett, M. P., Singh, J. K., & Clarke, R. B. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.019 · Cited by 94
Retinoic Acid Binds to the C2-Domain of Protein Kinase Cα
Ochoa, W. F., Torrecillas, A., Fita, I., Verdaguer, N., Corbalán‐García, S., & Gómez-Fernández, J. C. (2003) · Biochemistry · doi:10.1021/bi034713g · Cited by 86
Dietary carotenoids and the risk of invasive breast cancer
Mignone, L. I., Giovannucci, E., Newcomb, P. A., Titus‐Ernstoff, L., Trentham‐Dietz, A., Hampton, J. M., Willett, W. C., & Egan, K. M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24334 · Cited by 82
“inhibit tumor promotion in chemically induced cancers.(46) Previous epidemiologic studies of vitamin A and breast cancer have shown mixed results.”
BackgroundThe retinoic acid machinery in invertebrates: Ancestral elements and vertebrate innovations
Albalat, R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.029 · Cited by 101
Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor
Álvarez, S., Germain, P., Álvarez, R., Rodríguez‐Barrios, F., Gronemeyer, H., & de Lera, Á. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.010 · Cited by 85
Self-citationFu, H., Xie, B., Fan, G., Ma, S., Zhu, X., & Pan, S. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.03.019 · Cited by 81
Inhibition of IκB Kinase-β and Anticancer Activities of Novel Chalcone Adamantyl Arotinoids
Lorenzo, P., Álvarez, R., Ortiz, M. A., Álvarez, S., Piedrafita, F. J., & de Lera, Á. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800285f · Cited by 79
Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression
Fulan, H., Changxing, J., Yi, B. W., Wencui, Z., Chunqing, L., Wang, F., Li, D., Sun, D., Tong, W., Pang, D., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9811-y · Cited by 93
“Retinol and vitamins A, C, and E are hypothesized to reduce the risk of breast cancer due to their roles in the regulation of cell differentiation and apoptosis (retinol, vitamin A) [5], antiinflammation and antioxidant activities (vitamin E) [6], and prooxidant breakage of cellular oxidative DNA (vitamin C) Electroni…”
BackgroundRetinoic Acid Receptors in Acute Myeloid Leukemia Therapy
di Martino, O., & Welch, J. S. (2019) · Cancers · doi:10.3390/cancers11121915 · Cited by 85
“In general, RAR-RXR dimers bind DNA with high affinity at specific retinoic acid response elements (RAREs) in target gene promoters/enhancers [19,40].”
BackgroundCell cycle proteins in epithelial cell differentiation: Implications for breast cancer
Caldon, C. E., Sutherland, R. L., & Musgrove, E. A. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11474 · Cited by 86
Corepressor Recruitment by Agonist-Bound Nuclear Receptors
White, J. H., Fernandes, I., Mader, S., & Yang, X. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68004-6 · Cited by 95
Retinoid Metabolism and Diabetes Mellitus
Rhee, E., & Plutzky, J. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.167 · Cited by 85
“RA is clinically used for treatment of malignancies (e.g., promyelocytic leukemia, Kaposi’s sarcoma, and premalignancies) [14].”
BackgroundShirakami, Y., Gottesman, M. E., & Blaner, W. S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr275 · Cited by 75
Touma, S. E., Goldberg, J. S., Moench, P., Guo, X., Tickoo, S. K., Gudas, L. J., & Nanus, D. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1155 · Cited by 75
Prospects of tangeretin as a modulator of cancer targets/pathways
Raza, W., Luqman, S., & Meena, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105202 · Cited by 80
Wang, X., Qian, D. Z., Ren, M., Kato, Y., Wei, Y., Zhang, L., Fansler, Z. B., Clark, D., Nakanishi, O., & Пили, Р. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1092 · Cited by 82
“Retinoid resistance has been associated with loss or down-regulation of RARb2 expression in breast, prostate, colon, lung, and kidney cancers (3).”
BackgroundKato, Y., Salumbides, B. C., Wang, X.-F., Qian, D. Z., Williams, S., Wei, Y., Sanni, T. B., Atadja, P., & Pili, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0125 · Cited by 72
“Retinoids, a group of natural and synthetic vitamin A analogues, are essential for growth and cell differentiation of epithelial tissue and may affect cancer development (7, 8).”
BackgroundSchoofs, T., Rohde, C., Hebestreit, K., Klein, H., Göllner, S., Schulze, I., Lerdrup, M., Dietrich, N., Singh, S. A., Witten, A., et al. (2012) · Blood · doi:10.1182/blood-2012-08-448860 · Cited by 74
A Prospective Study of Smoking and Risk of Breast Cancer in Young Adult Women
Al‐Delaimy, W. K., Cho, E., Chen, W. Y., Colditz, G. A., & Willett, W. C. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.398.13.3 · Cited by 73
“Vitamin A has been hypothesized to reduce the risk of breast cancer through regulation of cell growth, differentiation, and death (28); some carotenoids can be converted to retinol and most have antioxidant activity that could potentially reduce oxidative damage to DNA caused by smoking (29).”
Lian, F., Hu, K., Russell, R. M., & Wang, X. (2006) · International Journal of Cancer · doi:10.1002/ijc.22111 · Cited by 82
“Retinoids, the important biologically active oxidative products from provitamin A carotenoids, play an important role in the prevention and treatment of a variety of chronic human diseases, including cancer.(12,13) The mechanism by which retinoids are able to elicit these effects resides in their ability to regulate g…”
BackgroundJones, J. W., Pierzchalski, K., Yu, J., & Kane, M. A. (2015) · Analytical Chemistry · doi:10.1021/ac504597q · Cited by 80
Yang, D., Luo, W., Wang, J., Zheng, M., Liao, X., Zhang, N., Lu, W., Wang, L., Chen, A., Wu, W., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.031 · Cited by 70
“It is known that poly lactic acid has good biocompatibility [57] and ATRA has antiproliferative activity against tumor cells [35].”
Zhao, X., Patton, J. R., Ghosh, S. K., Fischel‐Ghodsian, N., Shen, L., & Spanjaard, R. A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0414 · Cited by 75
Glasow, A., Prodromou, N., Xu, K., von Lindern, M., & Zelent, A. (2005) · Blood · doi:10.1182/blood-2004-03-1074 · Cited by 68
Su, M., Alonso, S., Jones, J. W., Yu, J., Kane, M. A., Jones, R. J., & Ghiaur, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127790 · Cited by 74
Tung, K., Wilkens, L. R., Wu, A. H., McDuffie, K., Hankin, J. H., Nomura, A. M. Y., Kolonel, L. N., & Goodman, M. T. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0550 · Cited by 67
“(Cancer Epidemiol Biomarkers Prev 2005;14(3):669–76)”
BackgroundInfluentialMolecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Gupta, S., Pramanik, D., Mukherjee, R., Campbell, N. R., Elumalai, S., de Wilde, R. F., Hong, S.-M., Goggins, M. G., De Jesus-Acosta, A., Laheru, D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2165 · Cited by 67
“The naturally occurring retinoid, all-trans retinoic acid (ATRA) or tretinoin, is approved in the clinic for the treatment of acute promyelocytic leukemia, and is currently being tested in clinical trials in additional tumor types (3).”
Reddy, E. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1014 · Cited by 76
“PML-RAR α in acute promyelocytic leukemia (APL) associates N-CoR/Sin3/HDAC1 complex with higher affinity than normal RAR α and its dissociation requires a pharmacological dose of all-trans retinoic acid (52).”
Selective retinoids and rexinoids in cancer therapy and chemoprevention
Zusi, F. C., Lorenzi, M. V., & Vivat, V. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02526-6 · Cited by 75
Dummer, R., Beyer, M., Hymes, K., Epping, M. T., Bernards, R., Steinhoff, M., Sterry, W., Kerl, H., Heath, K., Ahern, J. D., et al. (2012) · Leukemia & Lymphoma · doi:10.3109/10428194.2012.656625 · Cited by 65
Epigenetics wins over genetics: induction of differentiation in tumor cells
Lotem, J., & Sachs, L. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00054-8 · Cited by 72
Shimizu, M., Takai, K., & Moriwaki, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01045.x · Cited by 79
Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation
Christie, V. B., Barnard, J. H., Batsanov, A. S., Bridgens, C. E., Cartmell, E. B., Collings, J. C., Maltman, D. J., Redfern, C. P. F., Marder, T. B., Przyborski, S. A., et al. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b808574a · Cited by 69
Matsushima‐Nishiwaki, R., Okuno, M., Takano, Y., Kojima, S., Friedman, S. L., & Moriwaki, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg090 · Cited by 67
“Both RAR and RXR consist of three subtypes, -a, -b and -g , characterized by a modular domain structure.”
BackgroundInfluentialReducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy
Humbert, M., Seiler, K., Mosimann, S., Rentsch, V., Sharma, K., Pandey, A. V., McKenna, S. L., & Tschan, M. P. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00768-1 · Cited by 64
“Unfortunately, a variety of intrinsic resistance mechanisms in non-APL AML have been identified such as SCL overexpression, expression of PRAME and epigenetic silencing or mutation of RARA (Rice et al, 2004; Bullinger et al, 2013; Petrie et al, 2009; Altucci & Gronemeyer, 2001).”
BackgroundLoss of stearoyl‐CoA desaturase expression is a frequent event in prostate carcinoma
Moore, S. M., Knudsen, B. S., True, L. D., Hawley, S. J., Etzioni, R., Wade, C. B., Gifford, D., Coleman, I. M., & Nelson, P. S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20773 · Cited by 64
HDAC inhibitors in kidney development and disease
Brilli, L. L., Swanhart, L. M., de Caestecker, M. P., & Hukriede, N. A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2320-8 · Cited by 66
“However, some renal malignancies have shown resistance to this therapy [101, 102].”
BackgroundRieck, M., Meißner, W., Ries, S., Müller‐Brüsselbach, S., & Müller, R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050625 · Cited by 72
“The fact that atRA treatment resulted in an increased transcriptional activity in the presence of cotransfected RXR is presumably due to the presence of low levels of a RXR agonist in the preparation (Altucci and Gronemeyer, 2001) or metabolically produced atRA derivative(s).”
BackgroundSimonsen, J. B. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.009 · Cited by 68
Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids
Chlapek, P., Sláviková, V., Mazánek, P., Štěrba, J., & Veselská, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010132 · Cited by 73
“It was described that cells in which RARβ is deleted or its expression is impaired are selected in the cell population during the phase of rapid tumor growth [55].”
BackgroundDey, N., De, P. K., Wang, M., Zhang, H., Dobrota, E. A., Robertson, K. A., & Durden, D. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01352-06 · Cited by 62
“SK-N-BE(2) were cultured in Dulbecco’s modified Eagle’s medium supple-”
BackgroundMethodInfluentialCrosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
Yun, J., Pannuti, A., Espinoza, I., Zhu, H., Hicks, C., Zhu, X., Caskey, M. W., Rizzo, P., D'Souza, G., Backus, K. V., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.26 · Cited by 62
Nanobiotechnology applications of reconstituted high density lipoprotein
Ryan, R. O. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-28 · Cited by 74
“Retinoids, such as ATRA, are useful agents in cancer therapy as they exhibit a central role in cell growth, differentiation, and apoptosis [32,33].”
BackgroundSystemic retinoids in chemoprevention of non-melanoma skin cancer
Lens, M. B., & Medenica, L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.8.1363 · Cited by 65
A Novel Atypical Retinoid Endowed with Proapoptotic and Antitumor Activity
Cincinelli, R., Dallavalle, S., Merlini, L., Penco, S., Pisano, C., Carminati, P., Giannini, G., Vesci, L., Gaetano, C., Illy, B., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025593y · Cited by 62
Identification of a Novel Retinoid by Small Molecule Screening with Zebrafish Embryos
Sachidanandan, C., Yeh, J.-R. J., Peterson, Q. P., & Peterson, R. T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001947 · Cited by 68
“RA and its metabolites also play a crucial role in adult physiological functions such as promoting growth and differentiation, regulating apoptosis, and maintaining homeostasis in numerous tissues [27].”
Therapeutic effects of histone deacetylase inhibitors on heart disease
Chun, P. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01297-0 · Cited by 63
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages
Rao, E., Hou, Y., Huang, X., Wang, L., Wang, J., Zheng, W., Yang, H., Yu, X., Yang, K., Bugno, J., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.aba8426 · Cited by 62
Bernardo, A. R., Cosgaya, J. M., Aranda, A., & Jimenez-Lara, A. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.5 · Cited by 63
“RA derivatives are currently used in the treatment of APL and cutaneous T-cell lymphomas, but they are also effective on B-cell malignancies.(3) In addition to the induction of differentiation, RA is able to initiate several other biological programs that may contribute to its therapeutic potential.”
BackgroundMethodHDACs class II-selective inhibition alters nuclear receptor-dependent differentiation
Nebbioso, A., Dell’Aversana, C., Bugge, A. K., Sarno, R., Valente, S., Rotili, D., Manzo, F., Teti, D. V., Mandrup, S., Ciana, P., et al. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0043 · Cited by 66
Self-citationEpigenetic Therapies in MDS and AML
Griffiths, E. A., & Gore, S. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_13 · Cited by 66
Retinoid receptor subtype-selective modulators through synthetic modifications of RARγ agonists
Álvarez, S., Álvarez, R., Khanwalkar, H., Germain, P., Lemaire, G., Rodríguez‐Barrios, F., Gronemeyer, H., & de Lera, Á. R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.035 · Cited by 57
Self-citationSo, P.-L., Fujimoto, M. A., & Epstein, E. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2043 · Cited by 56
“Retinoids are vitamin A derivatives that are ligands for the retinoic acid receptor (RAR) and the retinoid X receptor (RXR) transcription factors and have been widely used to treat various cancers, such as leukemia and nonmelanoma skin cancers (7).”
BackgroundSo, P.-L., Lee, K., Hebert, J., Walker, P., Lu, Y., Hwang, J., Kopelovich, L., Athar, M., Bickers, D., Aszterbaum, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1927 · Cited by 57
“entiation but also may develop BCCs (1, 29).”
BackgroundPsidium guajava L. anti‐neoplastic effects: induction of apoptosis and cell differentiation
Bontempo, P., Doto, A., Miceli, M., Mita, L., Benedetti, R., Nebbioso, A., Veglione, M., Rigano, D., Cioffi, M., Sica, V., et al. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00797.x · Cited by 81
Self-citationShimizu, M., Tanaka, T., & Moriwaki, H. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0336-6 · Cited by 58
All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-κB
Kiningham, K. K., Cardozo, Z.-A., Cook, C. R., Cole, M. P., Stewart, J. C., Tassone, M., Coleman, M. C., & Spitz, D. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.015 · Cited by 55
“Dietary-derived ATRA is the main signaling retinoid in vivo and one of the most potent differentiation inducers for human neuroblastoma in vitro, mediating its actions in part through nuclear receptors [3].”
BackgroundOncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1
Osanai, M., Sawada, N., & Lee, G. (2009) · Oncogene · doi:10.1038/onc.2009.414 · Cited by 56
“Conversely, numerous clinical studies have provided support for the use of RA in the treatment of malignancies and premalignant lesions, as well as for chemoprevention (Lotan, 1996; Altucci and Gronemeyer, 2001).”
ResultWente, W., Brenner, M. B., Zitzer, H., Gromada, J., & Efanov, A. M. (2006) · Endocrinology · doi:10.1210/en.2006-1247 · Cited by 58
Sullivan, K. E., Rojas, K., Cerione, R. A., Nakano, I., & Wilson, K. F. (2017) · Oncotarget · doi:10.18632/oncotarget.16479 · Cited by 59
“Indeed, RA therapy is commonly used for the treatment of acute promyelocytic leukemia, leading to the differentiation of leukemic cells and often resulting in a complete remission [49-51].”
BackgroundJames, S. Y., Lin, F., Kolluri, S. K., Dawson, M. I., & Zhang, X.-K. (2003) · PubMed · Cited by 65
In the War Against Solid Tumors Arsenic Trioxide Need Partners
Subbarayan, P. R., & Ardalan, B. (2014) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-014-9617-8 · Cited by 55
“The disruption of PMLRARα fusion protein unblocked the maturation of promyelocytes [25].”
BackgroundLiu, C., Russell, R. M., & Wang, X. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2705 · Cited by 55
Villani, M. G., Appierto, V., Cavadini, E., Bettiga, A., Prinetti, A., Clagett‐Dame, M., Curley, R. W., & Formelli, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3362 · Cited by 54
“However, these activities do not explain all their growth-inhibitory and apoptotic effects (3).”
BackgroundInfluentialZuco, V., Zanchi, C., Cassinelli, G., Lanzi, C., Supino, R., Pisano, C., Zanier, R., Giordano, V., Garattini, E., & Zunino, F. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401304 · Cited by 57
Nuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53
“The prototype of cancer that always involves RARα gene translocation is acute promyelocytic leukemia (APL) [244,245,255–257].”
BackgroundSelf-citationGiannı̀, M., Kopf, E., Bastien, J., Oulad-Abdelghani, M., Garattini, E., Chambon, P., & Rochette-Egly, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200230200 · Cited by 52
AEG-1 Regulates Retinoid X Receptor and Inhibits Retinoid Signaling
Srivastava, J., Robertson, C. L., Rajasekaran, D., Gredler, R., Siddiq, A., Emdad, L., Mukhopadhyay, N. D., Ghosh, S., Hylemon, P. B., Gil, G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0421 · Cited by 53
Ross, A. C. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75008-7 · Cited by 53
“The model is also relevant to the human condition because RA and other retinoids, due to their ability to induce cell differentiation, are used therapeutically in the treatment of leukemias, other cancers and dermatological diseases (Altucci and Gronemeyer, 2001).”
BackgroundEfficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review
Bouriez, D., Giraud, J., Gronnier, C., & Varon, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113388 · Cited by 53
“for proteins implicated in cellular differentiation [15].”
BackgroundInfluentialKoushik, A., Hunter, D. J., Spiegelman, D. L., Anderson, K. E., Buring, J. E., Freudenheim, J. L., Goldbohm, R. A., Hankinson, S. E., Larsson, S. C., Leitzmann, M. F., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22076 · Cited by 52
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs
Altucci, L., Clarke, N., Nebbioso, A., Scognamiglio, A., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.019 · Cited by 64
Self-citationIshijima, N., Kanki, K., Shimizu, H., & Shiota, G. (2015) · Cancer Science · doi:10.1111/cas.12633 · Cited by 59
Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells
Hoffmann, S., Rockenstein, A., Ramaswamy, A., Çeli̇k, İ., Wunderlich, A., Lingelbach, S., Hofbauer, L. C., & Zielke, A. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.10.009 · Cited by 51
Brenes, O., Vargas, F. A., Gätjens-Boniche, O., & Díaz, C. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.02.007 · Cited by 52
Pathway Analysis for Drug Repositioning Based on Public Database Mining
Pan, Y., Cheng, T., Wang, Y., & Bryant, S. H. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci4005354 · Cited by 57
Impact of Epigenetic Dietary Components on Cancer through Histone Modifications
Gao, Y., & Tollefsbol, T. O. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150420102641 · Cited by 56
Wu, C., Shyu, R., Chou, J.-M., Jao, S., Chao, P., Kang, J., Wu, S., Huang, S.-L., & Jiang, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.015 · Cited by 51
Acute promyelocytic leukaemia: a review
Parmar, S., & Tallman, M. S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.8.1379 · Cited by 52
“The results thus indicate that the disruption of NBs are not the most critical insult necessary to induce a maturation arrest in APL blasts and that additional mechanisms are involved in its pathogenesis.”
BackgroundInfluentialHu, F., Wu, Z., Li, G., Teng, C., Liu, Y., Wang, F., Zhao, Y., & Pang, D. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1852-7 · Cited by 57
“Retinol, vitamin A, C and α-tocopherol are hypothesized to reduce the risk of breast cancer due to their roles in the regulation of cell growth, differentiation and apoptosis (retinol, vitamin A) (Altucci and Gronemeyer 2001), enhancing immune function, antiinflammation and its antioxidant activities (tocopherols) (Ag…”
BackgroundDrug conjugates—an emerging approach to treat breast cancer
Hasan, M., Leak, R. K., Stratford, R. E., Zlotos, D. P., & Witt‐Enderby, P. A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.417 · Cited by 50
“The HDAC inhibitors, butyric acid and MS‐275 (entinostat), were each conjugated to trans‐retinoic acid via an ester linkage.(3) Trans‐ retinoic acid induces differentiation and arrests proliferation in a wide range of cancer cells.”
MethodFenretinide: a prototype cancer prevention drug
Malone, W. F., Perloff, M., Crowell, J. A., Sigman, C. C., & Higley, H. R. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1829 · Cited by 50
樋口, 栄., Chandraratna, R. A. S., Hong, W. K., & Lotan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206235 · Cited by 50
Systemic cancer therapy: Evolution over the last 60 years
Dy, G. K., & Adjei, A. A. (2008) · Cancer · doi:10.1002/cncr.23651 · Cited by 65
“RAR-a exhibits a higher affinity for HDACs, which then ‘superrepresses’ RAR-a signaling, thus suppressing the ability of myelopoietic cells to differentiate into mature neutrophils.(158) Bexarotene, a synthetic retinoid analogue, belongs to a class of drug known as rexinoids that specifically activates RXRs and has a…”
BackgroundHDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 55
Self-citation
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.